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Introduction: Finding effective ways to help pregnant women quit smoking and maintain long-term 
abstinence is a public health priority. Electronic cigarettes (i.e., vaping) could be a suitable cessation 
tool in pregnancy for those who struggle to quit, however, healthcare professionals (HCP) must be 
informed about these devices to offer appropriate advice. This study used the Capability, 
Opportunity, Motivation and Behaviour (COM-B) model and Theoretical Domains Framework (TDF) 
to explore HCP attitudes towards vaping in pregnancy and postpartum; beliefs about the health risks 
of vaping; perceived barriers and facilitators of vaping in pregnancy; knowledge of current guidelines 
and policies; and training needs. 
Methods: Interviews (n=60) were conducted with midwives (n=17), health visitors (n=10), general 
practitioners (GPs) (n=15) and stop smoking specialists (n=18) across the UK. Interview transcriptions 
were analysed thematically using the framework approach and the COM-B.  
Results: Discussing vaping as a tool for quitting smoking in pregnancy was prevented by a lack of 
capability (limited knowledge of ECs, lack of training in smoking cessation); lack of opportunity 
(restricted by organisational policies and guidelines, lack of time and financial issues impacting on 
training), and negative social influences (sensationalist media and stigma associated with vaping in 
pregnancy); and lack of motivation (fear of future litigation and comebacks should adverse effects 
from vaping arise).  
Conclusions: Factors related to capability, opportunity and motivation were identified that influence 
HCPs attitudes and behaviours towards vaping in pregnancy. Gaps in knowledge and training needs 
were identified, which could inform the development of targeted vaping training.  
 
Implications 
E-cigarettes could be suitable in pregnancy for those struggling to quit smoking. However, 
healthcare professionals (HCP) must be informed about these devices to offer appropriate advice. 
These data extend our knowledge of factors influencing HCP attitudes and behaviours towards 
vaping in pregnancy. Generally, vaping was perceived as safer than cigarettes but a perceived lack of 
evidence, health and safety risks, dependency and regulation issues were concerning. Considering 
our findings, greater efforts are needed to ensure HCPs are sufficiently informed about vaping and 
guidelines available. More importance should be placed on training for all HCPs who have contact 
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Smoking is the main preventable cause of adverse pregnancy outcomes1,2, such as stillbirth, preterm 
birth and fetal growth restriction, as well as long-term effects, such as neurodevelopmental 
disorders3 and cancers4. Similar to other high income countries5, in England, average rates of 
smoking in pregnancy are 10.4%6, but in some areas prevalence is up to 23.3%6. Furthermore, nearly 
half of those who quit during pregnancy return to smoking by six months postnatally7. In addition, 
the child may be exposed to second-hand smoke (increasing risk of respiratory infections and 
sudden infant death syndrome8), and is more likely to become a smoker9. It is a public health priority 
to find effective ways to help pregnant women stop smoking and remain abstinent. 
 
In England, those who smoke in pregnancy are routinely referred to National Health Service (NHS) 
Stop Smoking Services to receive behavioural support and nicotine replacement therapy (NRT). 
However, trials have reported low adherence (7-25%) of NRT in pregnancy and, in placebo-
controlled trials, there is no evidence for NRT aiding smoking cessation (SC) in pregnancy10. Vaping 
could be an effective tool for pregnant women. There is some evidence for effectiveness in non-
pregnant smokers11,12, and vaping is increasingly used in pregnancy13,14 and for SC15–17.  
 
An evidence review by Public Health England (PHE)18 states that vaping is likely to be 95% safer than 
cigarettes, and is preferable to smoking, even by pregnant women. The UK Smoking in Pregnancy 
Challenge Group (SPCG) produced a guide for health care professionals (HCP), stating that “if a 
pregnant woman chooses to use an EC and if it helps her to quit smoking and stay smoke free, she 
should be supported to do so19.  
 
Concerns remain about the safety of vaping particularly relating to cytotoxicity and carcinogens20. 
Studies of vaping and health outcomes in pregnancy have been equivocal, due to small sample 
sizes21,22. There are also concerns and misperceptions around using nicotine in any form during 
pregnancy23. The controversy surrounding vaping may impact on HCP attitudes, thus influencing 
recommendations for their patients.  
 
Midwives are ideally placed to support SC in pregnancy. However, there is lack of attention to SC in 
clinical curricula in England and insufficient training for SC relapse prevention or practical skills for 
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Although studies have explored midwives’ and other HCP perceptions of SC treatment in general25,26, 
no studies have explored HCP perceptions of vaping in pregnancy, but many HCP report feeling 
unsure how to advise on vaping 27. The overall aim was to explore the attitudes of HCP in England 
towards vaping in pregnancy; their beliefs about health risks; knowledge of guidelines and 
recommendations; experience and current practice regarding vaping; previous training and future 
training requirements.  
 
Methods 
The study protocol was reviewed by external independent researchers prior to data collection, as 
part of the programme for registered reports with Nicotine and Tobacco Research. 
 
Study Design 
This was a qualitative study using in-depth interviews. The COM-B model of behaviour28 and the 
Theoretical Domains Framework (TDF)29 guided the analysis. COM-B focusses on three components: 
capability, opportunity and motivation (COM), which influence behaviour (B). The TDF comprises 14 
domains of theoretical constructs that could influence behaviour29, and extends COM-B, as each 
domain fits within one of the three components. The study is reported according to the consolidated 
criteria for reporting qualitative research (COREQ)30.  
 
Participants 
We aimed to conduct telephone interviews with approximately 18 each of four HCPs (midwives, 
health visitors (HV), general practitioners (GP), stop smoking specialists (SSS), or until reaching data 
saturation. Where possible, we purposively sampled across age, gender, years practicing, smoking 
status, ethnicity and region. Participants were entered into a prize draw for £100 vouchers.  
 
Procedure  
Recruitment involved various channels to ensure a wide range of views. We directly approached HCP 
through our networks and emailed contacts on our participant database and members of our 
Smoking in Pregnancy Steering Group. We approached people at management meetings (e.g. 
midwifery), to get ‘buy in’ from managers. For GP recruitment, we had support from the Primary 
Care Clinical Research Network, and as a GP, one of the authors disseminated study details to his 
network. The study was also advertised via staff newsletters and through social media (Twitter, 
Facebook). We used a snowball approach through all these channels. The University of Nottingham, 
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Interviews and analysis 
Interviews lasted 30-45 minutes. Information sheets and consent forms were emailed to participants 
beforehand. Verbal consent was recorded digitally before the interview. A topic guide was referred 
to during the interview (Appendix A). The COM-B28 and the TDF29 were used to ensure broad 
coverage of topics. We collected participant information on gender, age, years practicing, region, SC 
training, smoking and vaping status. We piloted the topic guide with each HCP group. 
 
A professional service (UK Transcription) transcribed interviews verbatim. Analysis was both 
deductive, through being informed by the COM-B and TDF and topic guide, and inductive, deriving 
from the spontaneous accounts of participants. A ‘Framework’ analytic approach to data analysis31 
produced an a priori framework with matrices mapping to the TDF and COM-B. After familiarisation 
with the transcripts, a selection from each HCP group was independently coded by two researchers 
(AH, JY) who agreed a ‘working’ coding framework which was then refined following further coding 
and meetings. The matrices were discussed with the team, to identify, label and refine the themes 
which best explained the data. NVivo version 12 software was used for managing data coding and 




Sixty interviews were conducted (17 midwives, 10 HV, 15 GPs, 18 SSSs), at which point data saturation 
was considered to have been reached. Half the participants worked full-time, over three-quarters 
were aged 26-55 years, female, white British and had been practicing for at least five years. They were 
from all nine regions of England, in addition to Wales and Northern Ireland. One-third were ex-
smokers, 3.3% were current smokers; 10% had vaped (Supplementary Table 1). Table 1 describes how 
the data aligns within the TDF and COM-B. 
 




Many practitioners were unaware of vaping guidelines, nor PHE’s statement that vaping is 95% safer 
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“Sometimes women ask…‘I’ve heard they’re not safe in pregnancy’. At the moment I’m going 
along with PHE advice, that they’re 95% safer than smoking”. (Midwife, 55). 
Others were sceptical about “how they got that percentage”. One HV said she wanted to see the 
evidence behind PHE’s statement before promoting the message. Most participants had not heard 
of the SPCG or their guidelines for HCP on vaping 19. Consequently, many HCP felt there was 
insufficient information: 
“Since e-cigarettes have come in, I don’t find there’s much out there from a midwifery point 
of view” (Midwife, 28).  
Some incorrectly believed UK guidance discourages vaping; one GP stated that the Royal College of 
Obstetricians and Gynaecologists does not recommend vaping in pregnancy. 
 
Lack of research 
Participants were concerned there was insufficient research on vaping, including long-term risks, 
especially during pregnancy.  
“…although I know they're broadly considered safe…I would reserve judgment on that until 
we’ve got some long-term studies.” (GP, 43) 
One GP commented the “apparent endorsement of something we don’t know about is…a concern” 
and “we are setting ourselves up for a public health disaster in the future.” They preferred patients 
to use evidence-based NRT. A few HCPs also questioned the validity of current evidence. A GP 
expressed surprise at recent changes in guidance, despite limited evidence. 
“I would be very cautious about advocating for pregnant women…do we have any evidence 
about which of the flavours crosses the placenta and has an impact on child development?” 
(GP, 48) 
 
Confusion and conflicting advice 
Limited knowledge of vaping and guidelines for staff, led to “uncertainty” and “confusion” over what 
they should recommend.  
 “There’s a lot of conflicting advice….confusion.…I’ve had a midwife email me saying she’d 
discussed with a couple of doctors who thought the risk of using an e-cigarette was the same 
as smoking”. (Midwife, 55) 
As a result of the confusion, it is likely patients are receiving mixed messages from the HCP they see.  
 “Everybody has different opinions...I think it depends which advisor they get, what sort of 
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Lack of training in SC and vaping 
Except for the SSSs, most participants had not received training on SC or vaping in pregnancy. One GP 
commented “no one is going to do that kind of training for GPs” and a midwife further added “we’re 
just not very well informed, as a profession.” Some HCPs reported receiving general training on SC and 
but not recently (e.g., when qualified). SSSs, on the other hand, received regular training, (e.g. through 
the National Centre for Smoking Cessation and Training (NCSCT)).  
 
HCPs who received some training, variations were observed across Trusts with respect to content, 
format, whether mandatory, and frequency. Training usually included risks of smoking and 
appropriate referrals, rather than how to provide support, and rarely anything on vaping. However, 
some trusts are making good progress: 
“What is pleasing is this year the trust…have agreed that brief advice on smoking is mandatory 
for everybody in Maternity Services…and there will be something about e-cigarettes on that. 
(Midwife, 55).” 
Most respondents agreed they would benefit from further training on vaping, stating the importance 
especially as they “become more popular”. There was a dearth in knowledge and a perceived need for 
training in four areas: Vape devices, evidence and policy, health and safety risks, and advice for 
patients. The specific knowledge gaps and needs are summarised in Table 2. 
 
INSERT TABLE 2 
Opportunity  
Environmental context and resources 
Organisational policies and guidelines 
Some practitioners felt there was insufficient guidance at work on vaping, or that key information is 
not “filtered through” to staff.  
“I don’t think we’ve received enough information about them…We haven’t had any guidance 
or policies in our trust, we haven’t had any real directives about e-cigarettes in pregnancy at 
all.” (HV, 54)  
Some were not allowed to recommend vaping because it is not NHS approved. Even if they had 
positive views towards vaping, they were often restricted by organisational policies. 
“We had an email from work saying, we can’t recommend e-cigarettes, it’s not a 
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Many reported “time is of the essence”. There is limited time with patients and limited time to keep 
up-to-date with research.  
“There’s so many guidelines, there’s so many things, we just don’t have the time to read 
every single guideline and change our practice”. [Midwife, 53] 
 
“They have a lot of other things to do……but, the midwives are the ideal ones to sit and talk 
to them, but they don’t have the time (SSS, 48). 
Social influences 
Participants reported conflicting media information about the safety of vaping; for example, 
whether it causes lung problems. Consequently, it was difficult to deal with inconsistent messages 
and to know what to advise.  
“You read things in the news, on social media, about conditions caused by e-cigs. So now I’m 
thinking I don’t know, as a professional I need to be advising women on stuff that I know” 
(Midwife, 49)  
 
“There’s a lot of scaremongering and obviously it’s difficult to know what’s true and what’s 
not” (Midwife, 32). 
 
Social influences also include perceived stigma. Some midwives looked at vapers as smokers, and felt 
there was a stigma to seeing pregnant women vaping.  
“They're looked upon kind of like smoking… we'd prefer people not to be using them”. (HV, 
58) 
 
“I’ve heard some midwives say they don’t like to see women use the e-cigarettes at all, and 
us midwives are well known for having very strong views on things.” (Midwife, 59) 
 
Motivation 
Professional role and identity 
All participants reported assessing smoking and discussing risks of smoking, however across all 
groups, many suggested it was the responsibility of someone else to discuss SC and provide support, 
saying “it’s not down to me”. Often, they felt their responsibility ended with referring to SC services, 
with no more discussions throughout pregnancy: 
“We don’t go into detail because our prime goal is to get them to accept a referral… the 
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Some reasoned there was “enough information out there about smoking” and further discussion 
would come across as “preaching.” Others were more proactive.  
“During a consultation, I will do some brief intervention and I will even make the appointment 
myself with one of our nurses.” (GP, 50). 
 
Beliefs about consequences  
There was no consensus on vaping, but some participants reported several positive aspects. It was 
generally perceived as a tool for SC. They felt it was an alternative, “something within the armoury” 
or “an extra tool” available to women to quit smoking. It was seen as both a positive opportunity for 
smokers (e.g., “a step in the right direction”, “a transition”, “pathway of stopping smoking” and “a tool 
to bridge smoking and non-smoking”) and as a compromise (“a less worrying option”, “the middle 
ground”).  
“If I’ve got a woman who comes to clinic…but she doesn’t want refering anywhere, I would 
suggest she could purchase an e-cigarette, which would be a safer alternative.” (Midwife, 55) 
 
Another positive theme related to vaping as safer than smoking. Respondents often reported that 
thousands of chemicals and harmful toxins are found in cigarettes compared with just a few in vaping; 
hence it is a “cleaner” way to get nicotine.  
“They are much safer because tobacco has got a lot more chemicals in them…if you have one 
or two chemicals in something and you have 4,000 in something else, obviously by default it’s 
going to be safer” (Midwife, 39). 
 
They mentioned the health risks of tobacco smoke are well-known and vaping is a better option for 
maternal and child health. One GP asserted the benefits of vaping outweigh the risks of smoking 
cigarettes, with another one similarly remarking: “anything’s better than the cigarette.” Others talked 
about harm reduction and that “significant gains are to be made in terms of risk reduction and harms 
to the patient” when using an e-cigarette.  
 
A few success stories were reported, such as engagement with SC services increasing due to vaping; 
people with past unsuccessful quit attempts stop smoking by vaping; pregnant women vaping and 
eventually switching to NRT products and then coming off nicotine completely. Some HCPs asserted 
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While participants reported the benefits of vaping relative to normal cigarettes, they tended to qualify 
their statements due to the uncertainty around vaping. Some HCPs emphasised complete nicotine 
abstinence is preferable. One HCP commented that vaping is not necessary as there are already 
sufficient tools available for someone to quit: 
“I always thought…it was a tool that wasn’t necessary because if they’re coming wanting to 
quit, they’ve got that motivation and we’ve got the NRT we can use” (SSS, 25). 
 
Others believed vaping to be harmful and had concerns about limited evidence. While some 
participants acknowledged vaping was safer than smoking, they also felt “it’s not completely safe.” 
They were unclear about its harms, especially on the foetus, as well as its long-term effects on the 
lungs, with some HCPs bringing up the possibility of “popcorn lungs”. 
 
A common concern was that long-term impacts are unknown. The flavours and perfumes in vapour 
were often brought up as potential risks, chemicals that “can't be brilliant for your chest.” Children 
were also seen as vulnerable to toxicity when exposed to vapour. Dual tobacco smoking and vaping 
were additional concerns. Some HCPs expressed strong views: 
“My opinion is I just don’t like smoking. I can’t see why you want to draw anything into your 
lungs other than air…they’re not designed for you to draw chemicals into. (HV, 53). 
 
Some HCP associated the risks of vaping as the same as cigarettes, with one midwife stating “if you 
have an infection it’s worse for you to be smoking [an e-cig] than it is normal cigarettes”, and a SSS 
stated that people who vape have “the same risk of getting COPD as a smoker”. Others treated 
vaping the same as smoking in terms of information given: 
“I usually say to my clients because of the lack of information I would treat them, at present, 
the same as cigarettes” (HV, 58) 
 
Many participants felt vaping sustains an addiction and were worried about long-term dependency. 
They viewed vaping as “swapping one addictive behaviour for another… without actually dealing 
with the addiction”.  
“It feels like I’m just sanitising what’s a bad habit…I’m not clear that the evidence on e-
cigarettes in relation to pregnancy is out there to make it safe for me to say that it’s okay.” 
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It was suggested that if people are vaping to quit smoking then they should be aiming to quit vaping 
as soon as possible. 
 
Beliefs about capabilities  
When considering “beliefs about capabilities” many practitioners reported feeling unconfident or 
uncomfortable giving vaping advice due to lack of knowledge, conflicting information seen/heard 
and the overall lack of evidence on the product as mentioned above. 
“I don’t know enough about them. I wouldn’t feel comfortable advising…I’d rather they went 
down routes that have got more trials and evidence…” (HV, 44) 
 
A few respondents appeared to be “fairly confident” or were confident in some areas, but not in 
others (for example in discussing efficacy but not in recommending brands); they would give advice 
as long as it was within the sphere of what they felt comfortable with (for instance, saying the “strap 
line” vaping is safer but not engaging further). 
“I feel confident in the knowledge I’ve got… I don’t know what else I would say other than it’s 
safer than smoking… that’s the bottom line.” (Midwife, 52) 
 
A few participants mentioned that while they feel confident, this may not be the case for other 
HCPs, because “not all midwives are confident to talk about quitting smoking, never mind e-
cigarettes”. 
 
Emotion      
A fear of vaping 
Some participants had a fear of future litigation and comebacks should adverse effects arise as a 
result of vaping, with one person commenting “this apparent endorsement of something we don’t 
know about is, a concern”.  
“I’m just worried, particularly with people with existing lung conditions like COPD, what are 
the long-term effects of using those devices. Are we not storing up a lot more issues in 10 
years’ time?” (SSS, 64).  
 
 “I have very senior consultants…telling people they shouldn’t be using an e-cig…Because I 
think they're afraid of any comeback on them if they say to use an e-cig and there's an 
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There were also safety concerns about the liquids exploding and batteries leaking, sometimes heard 
from media stories, and fear that the devices might “blow up or catch on fire”. Many also had 
concerns about the effects on the foetus and maternal outcomes: 
 “I have seen some of the studies that suggest there’s a link between still birth and possible 
miscarriage when e-cigarettes are used, so, I do not feel happy recommending them” (SSS, 
64).  
 
Many had concerns about advising on vaping without prior training, and feared recommending 
vaping as it is an unregulated market.   
 “You can’t monitor the efficacy or the quality of those products…that’s my worry about using 
e-cigarettes…because I’m not clear how those places are regulated and I’m pretty certain 
what you buy off eBay and Amazon isn’t particularly well-regulated”. (HV, 53) 
 
Discussion  
The COM-B and TDF were used to identify and conceptualise the factors which explain or determine 
HCP attitudes and behaviours regarding vaping in pregnancy. We showed HCP behaviour (discussing 
vaping for SC in pregnancy) was facilitated by having the capability (knowledge and skills to discuss 
vaping); opportunity (environmental situations through appropriate organisational policies and 
access to training); and motivation (beliefs about consequences of smoking and/or vaping; and the 
belief that providing SC support is the responsibility of someone else). Conversely, this behaviour 
was prevented by lack of capability (limited knowledge of evidence/guidelines, and lack of 
confidence giving advice); lack of opportunity (restricted by organisational policies/guidelines, lack of 
time and financial issu s impacting on training), and negative social influences (sensationalist media 
reporting and stigma associated with vaping); and lack of motivation (fear of future litigation).  
Our findings are consistent with research showing HCP feel they have limited capability in discussing 
vaping. Most nurses and GPs feel ill-equipped to discuss vaping with their patients due to a lack of 
knowledge of risks and benefits33. Practitioners had a lack of knowledge of appropriate guidelines, 
and in agreement with our study, it would seem dissemination strategies for guidelines are not 
effective in reaching frontline staff. Consequently, staff are often far more cautious about vaping 
than guidelines advise. Improved dissemination of national guidelines on tobacco harm reduction 
and vaping has been called for, as many HCP are overly cautious and have misperceptions about 
vaping34. A lack of capability among HCP, to appropriately discuss vaping, is likely to impact on the 
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in this advice33,35–37.  
A review of qualitative research identified that both the professional role of participants and the 
organisational context in which they worked could act as either barriers or facilitators to an 
individual’s ability to provide SC support to pregnant or post-partum women38, and these barriers 
might similarly relate to discussing vaping for SC. Lack of time has frequently been reported as a 
barrier for providing SC care for midwives39–41, as they struggle to find time during busy antenatal 
appointments26. Many participants reported lack of time to attend training, to read documents, and 
to discuss SC and vaping with patients.  
Social factors also influenced behaviour. The media was seen to report conflicting views. A review on 
the beliefs and attitudes of HCPs toward EC42 found beliefs are influenced by media stories. Negative 
media about vaping tends to be more prevalent than positive messages, and since HCPs report a lack 
of guidance, it is likely that media sources are influential43.   
The fear that vaping may lead to adverse effects in years to come was shared by many participants. 
Similar views have also been expressed by GPs and nurses in previous interviews33, and this is a 
potential barrier to discussing vaping with patients. Fears were also expressed over potential harms 
to the developing foetus, perhaps suggesting an over-cautious approach among HCP caring for 
pregnant women.  
When considering attitudes towards vaping specifically in pregnancy, Cooper44 found SSS were 
generally positive about vaping but still had concerns about a perceived lack of evidence. This finding 
supports our study in that it was the SSS who were generally most confident about discussing 
vaping. This is most likely due to having more training than the other practitioner groups. However, 
not discussing SC during pregnancy is a missed opportunity to provide Very Brief Advice (VBA).  
Future research 
Considering our findings, clearly, greater efforts are needed to ensure HCPs are sufficiently informed 
about vaping and the evidence and guidelines available. More importance should be placed on 
training for all HCPs who have contact with pregnant women. Indeed, a recent vaping priority setting 
exercise45, inviting the public and health professionals to submit vape questions they want 
answering by research, resulted in two questions on pregnancy prioritised in the top 10 (health 
effects of vaping in pregnancy; and whether vaping in pregnancy can encourage SC and reduce 
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Strengths and limitations 
The COM-B and TDF are established theoretical frameworks and their use strengthens our study. We 
recruited participants from many different regions across the UK, however our participants were an 
opportunistic sample and therefore may have been more motivated towards discussing vaping. 
Some GPs reported rarely seeing pregnant smokers due to working in areas of low prevalence of 
smoking in pregnancy. Their limited experience with this population could mean their views are 
different from GPs in other areas.  
 
Conclusions 
The application of the COM-B identified multiple factors influencing HCP attitudes and behaviours 
towards vaping in pregnancy. Generally, vaping was perceived as safer than cigarettes but a 
perceived lack of evidence, health and safety risks, dependency and regulation issues were dominant 
concerns. Although research on vaping in pregnancy is limited, there are sufficient UK guidelines 
available to assist HCP in supporting pregnant smokers, however this information is not filtering 
down to practitioners, leading to confusion. Gaps in knowledge, and training needs were identified 
which could inform the development of targeted vaping training for HCP.   
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Table 1: Summary of key findings for each COM-B and TDF domain 
Com-B TDF Broad Issue 
 





Knowledge Lack of knowledge 
on vaping  
There was a lack of knowledge to be able to give appropriate advice.  Barrier 




































Substantial research exists but it was not filtering down to frontline staff giving advice. Barrier 
Many staff were not provided with guidance, information or resources through work.  Barrier 
Often, training or resources for staff did not include information about vaping.  Barrier 
Lack of evidence on 
vaping 
There was a perceived lack of research and data on vaping in pregnancy, and a worry that it 
might turn out to be worse than cigarettes or cause issues long-term.  
Barrier 
Lack of regulation Lack of regulation in terms of quality and usage. Barrier 
 
Lack of time 
Lack of time to attend training, to read documents, or to discuss SC with patients. Barrier 
Some HCPs feel the pregnancy is not enough time to make a difference. Barrier 













Some HCP were told at work that they cannot recommend or discuss vaping.  Barrier 
Some trusts have no real directives about vaping, therefore advice given to patients was 
sometimes dependent on individual views.  
Barrier 
There was a heavy reliance on some staff to do smoking cessation with patients. Barrier 
Many guidelines were available, but they were conflicting. WHO has not issued a positive 
stance on vaping but PHE has. 
Barrier 
Mandatory training was updated to include smoking cessation and vaping. Facilitator 
Some services tried different approaches to vaping. Examples included giving discounts to a 
local vape shop and offering a free voucher scheme sponsored by vaping companies.  
Facilitator 
Some workplaces had an active guideline group that looked at any new documentation from 
the government, and then considered whether the trusts guidance needed to change. 
Facilitator 
Old policies were changed based on new training that had taken place.  Facilitator 
Midwives were encouraged to do NCSCT training. Facilitator 
Commissioners pushed for services to be vape friendly, leading to change in staff attitudes. Facilitator 
Offering a flexible service and allowing women to try different products. Facilitator 
Financial issues Cascading and rolling out vaping evidence to frontline staff costs money. Barrier 
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Friends and family 
influences 






Media and Google 
influences 
The media often portrays that vaping is not healthy, causes lung problems, and encourages 
youth uptake. However, other media reports say vaping is less harmful. 
Barrier/ 
facilitator 
Sensationalist media reports are mostly based on very small or oorly designed studies.  Barrier 
Google and the news were used as information sources for vaping.  Barrier 
Midwives were often influenced by what was reported in the media. Barrier 
 
Stigma 
Some midwives considered vapers to be smokers. Barrier 





role / identity 
Perceived 
responsibility 
Although all reported discussing smoking and assessing the risks, there were mixed opinions 




Preferences Advisors had varying views on vaping, including at both extremes of the spectrum. Barrier 
Beliefs about 
capabilities 
Lack of confidence HCP had a lack of confidence to give advice, often due to their lack of knowledge on vaping.  Barrier 
Emotion Fear A fear of future litigation and comebacks should adverse effects result from vaping. Barrier 
There were strong views on tobacco meaning vaping was looked upon suspiciously. Barrier 








/ntr/article-abstract/doi/10.1093/ntr/ntaa126/5867497 by London School of H
ygiene & Tropical M













Table 2: Areas where respondents had specific knowledge gaps and needs 
Area Specific knowledge gaps and needs 
 
Vape devices  What are the different brands available and how do they vary in terms 
of ingredients, strengths, effectiveness, costs, usability, popularity? 
 What does should they be recommending? 
 How do they advise someone to quit vaping without relapsing to 
smoking? 




 What guidelines are currently available for HCP? 
 What is the official position statement of vaping from authoritative 
organisations? 
 How did PHE arrive at the 95% figure of vaping reduced harm relative 
to cigarettes? 
 How does vaping compare to NRT in terms of harm and quit rates, and 
cost-effectiveness 




 What are the long-term impacts of vaping, including harms to mother 
and baby? 
 Is nicotine safe in pregnancy? 
 What are the side effects of nicotine? 
 Is there a risk of harm from second-hand vaping? 




 Can vaping devices be obtained via prescription? 
 How much risk is reduced by switching? 
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